Gilead Sciences Announced Definitive Agreement To Acquire Arcellx For $115 Per Share In Cash And $5 Per Share Contingent Value Right
Arcellx, Inc. +0.10% Post
Gilead Sciences, Inc. -0.48% Post
Arcellx, Inc. ACLX | 115.00 115.00 | +0.10% 0.00% Post |
Gilead Sciences, Inc. GILD | 139.77 139.53 | -0.48% -0.17% Post |
Gilead Sciences Announced Definitive Agreement To Acquire Arcellx For $115 Per Share In Cash And $5 Per Share Contingent Value Right
